The Traderszone Network

3 August, 2017 by The TZ Newswire Staff Comments Off on ex-dividend and options

ex-dividend and options

I’m long 5 calls on HCN, which is going ex-D tomorrow. .87 dividend. Should I close and re-open or do adjusted options take care of the problem? (Feel like an idiot – I’ve never cracked the option dividend crossover code.)
thanks for any help.

3 August, 2017 by The TZ Newswire Staff Comments Off on Good news: Employees are starting to get serious about saving for retirement

Good news: Employees are starting to get serious about saving for retirement

Two recent studies show some workers are saving for retirement, after all.
read more

3 August, 2017 by The TZ Newswire Staff Comments Off on The Margin: Trump’s long vacation is needed to stop leaks to the White House press

The Margin: Trump’s long vacation is needed to stop leaks to the White House press

Some good news for President Donald Trump: after he completes a two-week vacation to his New Jersey golf club that starts Friday, the problem of White House leaks to the press will be plugged.

read more

3 August, 2017 by The TZ Newswire Staff Comments Off on Opinion: Dow 22,000 Is (Even More) Stupid

Opinion: Dow 22,000 Is (Even More) Stupid

The problem’s not the 20,000 or the 22,000. It’s the Dow.

3 August, 2017 by The TZ Newswire Staff Comments Off on Biotech Correction Could Offer Buying Opportunity

Biotech Correction Could Offer Buying Opportunity

Biotech funds have entered corrections and could set off fresh buying signals when they reach breakout support.

3 August, 2017 by The TZ Newswire Staff Comments Off on Apple: Barclays Ups Price Target, Sees Headwinds

Apple: Barclays Ups Price Target, Sees Headwinds

Barclays raised its price target on Apple—still below its current price—but warned of headwinds.

3 August, 2017 by The TZ Newswire Staff Comments Off on Teva shares plummet 18% on cheaper generic drug prices, pulling rivals lower

Teva shares plummet 18% on cheaper generic drug prices, pulling rivals lower

Generic drug prices have been going down, and the trend isn’t expected to go away soon.
read more